Pathways Leading to Phosphorylation of P450c17 and to the Posttranslational Regulation of Androgen Biosynthesis
Open Access
- 10 January 2008
- journal article
- other
- Published by The Endocrine Society in Endocrinology
- Vol. 149 (5) , 2667-2677
- https://doi.org/10.1210/en.2007-1527
Abstract
Cytochrome P450c17 (P450c17) is the single enzyme that catalyzes steroid 17α-hydroxylase and 17,20 lyase activities and hence is the crucial decision-making step that determines the class of steroid made in a steroidogenic cell. Although both activities are catalyzed on a single active site, the ratio of these activities is regulated by posttranslational events. Serine phosphorylation of P450c17 increases 17,20 lyase activity by increasing the enzyme’s affinity for its redox partner, P450 oxidoreductase. We searched for the relevant kinase(s) that phosphorylates P450c17 by microarray studies and by testing of kinase inhibitors. Microarrays show that 145 of the 278 known serine/threonine kinases are expressed in human adrenal NCI-H295A cells, only six of which were induced more than 2-fold by treatment with 8-Br-cAMP. Key components of the ERK1/2 and MAPK/ERK kinase (MEK)1/2 pathways, which have been implicated in the insulin resistance of PCOS, were not found in NCI-H295A cells, implying that these pathways do not participate in P450c17 phosphorylation. Treatment with various kinase inhibitors that probe the protein kinase A/phosphatidylinositol 3-kinase/Akt pathway and the calcium/calmodulin/MAPK kinase pathway had no effect on the ratio of 17,20 lyase activity to 17α-hydroxylase activity, appearing to eliminate these pathways as candidates leading to the phosphorylation of P450c17. Two inhibitors that target the Rho-associated, coiled-coil containing protein kinase (ROCK)/Rho pathway suppressed 17,20 lyase activity and P450c17 phosphorylation, both in NCI-H295A cells and in COS-1 cells transfected with a P450c17 expression vector. ROCK1 phosphorylated P450c17 in vitro, but that phosphorylation did not affect 17,20 lyase activity. We conclude that members of the ROCK/Rho pathway act upstream from the kinase that phosphorylates P450c17 in a fashion that augments 17,20 lyase activity, possibly acting to catalyze a priming phosphorylation.Keywords
This publication has 70 references indexed in Scilit:
- Mutagenesis of putative serine–threonine phosphorylation sites proximal to Arg255 of human cytochrome P450c17 does not selectively promote its 17,20-lyase activityFertility and Sterility, 2006
- Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signalingAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- A Regulatory Role for p38δ MAPK in Keratinocyte DifferentiationJournal of Biological Chemistry, 2003
- Protein Phosphatase 2A and Phosphoprotein SET Regulate Androgen Production by P450c17Published by Elsevier ,2003
- AGC protein kinase phosphorylation and protein kinase CBiochemical Society Transactions, 2001
- AGC protein kinase phosphorylation and protein kinase CBiochemical Society Transactions, 2001
- Activation of LIM Kinases by Myotonic Dystrophy Kinase-related Cdc42-binding Kinase αJournal of Biological Chemistry, 2001
- Current Concepts in the Polycystic Ovary SyndromeAnnual Review of Medicine, 2001
- Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.Journal of Clinical Investigation, 1995
- Pituitary-Ovarian Responses to Nafarelin Testing in the Polycystic Ovary SyndromeNew England Journal of Medicine, 1989